SONM appears to have undergone a complete business transformation, changing from Sonim Technologies (rugged enterprise communications) to DNA X, Inc. with dramatically deteriorating financials.
This represents a fundamental corporate change that has eliminated the previous business model entirely, as evidenced by the removal of all Sonim Technologies references and business descriptions. The massive reduction in outstanding shares (76% decrease) combined with severe financial deterioration suggests either a reverse merger, major restructuring, or business failure requiring investor immediate attention.
The financial picture shows a company in severe distress with operating cash flow deteriorating 177% to -$23.5M, cash reserves plummeting 76% to just $1.3M, and accounts receivable collapsing 83% indicating lost business relationships. While operating losses technically "improved" due to lower revenue base, the 13x increase in debt, 9x surge in interest expense, and 8x jump in R&D spending suggest a struggling entity burning through capital rapidly. The overall trajectory points to a company facing potential liquidity crisis within the filing period.
Debt increased 1299.2% — substantial leverage increase; assess whether deployed for growth or covering losses.
Interest expense surged 874.2% — significant debt increase or rising rates materially impacting earnings.
R&D investment increased 703.3% — signals commitment to future product development, though near-term margin impact.
Capital expenditure jumped 494.4% — major investment cycle underway; assess returns on deployment.
Operating cash flow fell 177.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Cash declined 75.6% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Inventory surged 63% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →